Pfizer Arthritis Drug Has Safety Risks, FDA Report Says
The U.S. Food and Drug Administration said Monday that clinical trials of Pfizer Inc.'s proposed rheumatoid arthritis drug revealed "serious safety concerns," including increased risks of cancer and serious infections, two...To view the full article, register now.
Already a subscriber? Click here to view full article